Literature DB >> 23385671

Protective role of atorvastatin against doxorubicin-induced cardiotoxicity and testicular toxicity in mice.

S V V S Ramanjaneyulu1, P P Trivedi, S Kushwaha, A Vikram, G B Jena.   

Abstract

Doxorubicin (DOX), a potent chemotherapeutic agent, is widely used for the treatment of various malignancies. However, its clinical uses are limited due to its dose-dependent adverse effects particularly cardiac and testicular toxicities. DOX-induced toxicity is mainly due to the induction of oxidative stress. Atorvastatin (ATV), a 3-hydroxy 3-methyl glutaryl coenzyme A reductase inhibitor, with lipid-lowering activity, acts as an antioxidant at lower doses. It possesses pleiotropic effects independent of cholesterol-lowering property usually shown at lower doses, which include antioxidant and anti-inflammatory activities. The present study was aimed to investigate the possible protection exerted by atorvastatin against oxidative stress and DNA damage induced by DOX in the heart and testes of mice. The protective role of ATV in the heart and testes of DOX-treated mice was evident from the amelioration of oxidative stress, DNA and cellular damage. The present study clearly indicates that ATV offers a significant protection against DOX-induced oxidative stress and DNA damage in the heart and testes of mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385671     DOI: 10.1007/s13105-013-0240-0

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  52 in total

1.  Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.

Authors:  Himanshu Sharma; Rahila Ahmad Pathan; Vinay Kumar; Saleem Javed; Uma Bhandari
Journal:  Int J Cardiol       Date:  2010-05-07       Impact factor: 4.164

2.  Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes.

Authors:  S M DeAtley; M Y Aksenov; M V Aksenova; B Harris; R Hadley; P Cole Harper; J M Carney; D A Butterfield
Journal:  Cancer Lett       Date:  1999-02-08       Impact factor: 8.679

3.  Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.

Authors:  Ahmed A Elberry; Ashraf B Abdel-Naim; Essam A Abdel-Sattar; Ayman A Nagy; Hisham A Mosli; Ahmed M Mohamadin; Osama M Ashour
Journal:  Food Chem Toxicol       Date:  2010-02-08       Impact factor: 6.023

Review 4.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

5.  Hesperetin protects testicular toxicity of doxorubicin in rat: role of NFκB, p38 and caspase-3.

Authors:  P P Trivedi; D N Tripathi; G B Jena
Journal:  Food Chem Toxicol       Date:  2010-12-17       Impact factor: 6.023

6.  DNA methyltransferase I is a mediator of doxorubicin-induced genotoxicity in human cancer cells.

Authors:  Hwee Hong Tan; Alan George Porter
Journal:  Biochem Biophys Res Commun       Date:  2009-03-16       Impact factor: 3.575

7.  Intervention of D-glucose ameliorates the toxicity of streptozotocin in accessory sex organs of rat.

Authors:  A Vikram; D N Tripathi; P Ramarao; G B Jena
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-18       Impact factor: 4.219

8.  Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.

Authors:  Alexander Riad; Jing Du; Sebastian Stiehl; Dirk Westermann; Zarah Mohr; Meike Sobirey; Wolfram Doehner; Volker Adams; Matthias Pauschinger; Heinz Peter Schultheiss; Carsten Tschöpe
Journal:  Eur J Pharmacol       Date:  2007-05-24       Impact factor: 4.432

9.  Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.

Authors:  Guo-Chang Fan; Xiaoyang Zhou; Xiaohong Wang; Guojie Song; Jiang Qian; Persoulla Nicolaou; Guoli Chen; Xiaoping Ren; Evangelia G Kranias
Journal:  Circ Res       Date:  2008-10-23       Impact factor: 17.367

10.  Chemical induction of sperm abnormalities in mice.

Authors:  A J Wyrobek; W R Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

View more
  8 in total

Review 1.  Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.

Authors:  Saro H Armenian; Gregory T Armstrong; Gregory Aune; Eric J Chow; Matthew J Ehrhardt; Bonnie Ky; Javid Moslehi; Daniel A Mulrooney; Paul C Nathan; Thomas D Ryan; Helena J van der Pal; Elvira C van Dalen; Leontien C M Kremer
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

Review 2.  Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies.

Authors:  Nonhlakanipho F Sangweni; Derick van Vuuren; Lawrence Mabasa; Kwazi Gabuza; Barbara Huisamen; Sharnay Naidoo; Reenen Barry; Rabia Johnson
Journal:  Front Cardiovasc Med       Date:  2022-06-22

Review 3.  Pleiotropic effects of statins: new therapeutic targets in drug design.

Authors:  Onkar Bedi; Veena Dhawan; P L Sharma; Puneet Kumar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-05       Impact factor: 3.000

4.  Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.

Authors:  Noha M Mounier; Sara A Wahdan; Amany M Gad; Samar S Azab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-23       Impact factor: 3.000

Review 5.  Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.

Authors:  Christian Henninger; Gerhard Fritz
Journal:  Cell Death Dis       Date:  2017-01-19       Impact factor: 8.469

Review 6.  The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.

Authors:  Kerstin N Timm; Damian J Tyler
Journal:  Cardiovasc Drugs Ther       Date:  2020-04       Impact factor: 3.727

7.  Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs.

Authors:  Carlota Oleaga; Catia Bernabini; Alec S T Smith; Balaji Srinivasan; Max Jackson; William McLamb; Vivien Platt; Richard Bridges; Yunqing Cai; Navaneetha Santhanam; Bonnie Berry; Sarah Najjar; Nesar Akanda; Xiufang Guo; Candace Martin; Gail Ekman; Mandy B Esch; Jessica Langer; Gladys Ouedraogo; Jose Cotovio; Lionel Breton; Michael L Shuler; James J Hickman
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

Review 8.  Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.

Authors:  Nichanan Osataphan; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cell Mol Med       Date:  2020-04-26       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.